Showing results (91-100 of 254) with videos related to

Sort By:
Pageof 26
Leukemia & Lymphoma|February 6, 2009
Predicting durable remissions following thalidomide therapy for relapsed myelomaHang Quach, Linda Mileshkin, John F Seymour, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 21, 2021
Advances in Frontline Management of Peripheral T-cell LymphomaChathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, et al.
Investigational New Drugs|February 5, 2013
A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumorsSunil Sharma, Joachim Beck, Monica Mita, et al.
Cancers|October 29, 2020
Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell LymphomaChathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 18, 2014
The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantationShaun Fleming, Simon J Harrison, Piers Blombery, et al.
Seminars in Radiation Oncology|December 13, 2024
Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024Belinda A Campbell, H Miles Prince, Karin Thursky, et al.
Expert Review of Clinical Immunology|July 14, 2025
Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndromeFriyana K Bhabha, Carrie Van Der Weyden, Joshua M L Casan, et al.
The Australasian Journal of Dermatology|March 9, 2023
CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer CentreFriyana K Bhabha, Christopher McCormack, Belinda A Campbell, et al.
The British Journal of Dermatology|December 10, 2024
Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causesBelinda A Campbell, Peter D Baade, Paramita Dasgupta, et al.
Leukemia & Lymphoma|July 15, 2006
Development of a predictive population survival model according to the cytogenetic response rate for patients with chronic myeloid leukemia in the chronic phaseRudolf J Schrover, Michael A Adena, Richard De Abreu Lourenco, et al.
Pageof 26